EUROPHARMEDTECH (Private limited company)

EPMT
BE 0685.431.593 Active ●Avenue Charles-Quint 400, 1083 Ganshoren

EUROPHARMEDTECH is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0685.431.593. It was founded on 28-11-2017. Its registered office is in Ganshoren. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -28 814 and a loss of € 69 941. These accounts report 1.2 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 14-10-2026.

Company information

Status
Active
Enterprise number
BE 0685.431.593
VAT registered
Yes
Founded
28-11-2017
Latest accounts
2025
Employees
1.2 FTE
Region
Brussels-Capital
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue Charles-Quint 400, 1083 Ganshoren
Main activity
Scientific research and development
NACE activities
72101 Recherche-développement en biotechnologie
62200 Activités de conseil en informatique et de gestion d’installations informatiques
62900 Autres activités de service informatique
70200 Activités de conseil pour les affaires et autre conseil de gestion
73300 Activités de conseil en relations publiques et communication

Key figures of EUROPHARMEDTECH

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -69 941-31 %€ -53 223€ 75 400+77 %€ 42 597
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -28 814€ 41 127-56 %€ 94 350+398 %€ 18 949
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 54 960-41 %€ 93 699-48 %€ 179 459+62 %€ 110 553
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -5 941€ 10 453-94 %€ 178 395+44 %€ 123 995
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
1.20 %1.20 %1.2+9 %1.1

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Ganshoren.

CompanyTown
SANABEL CONSULTING 1083 Ganshoren
R-Qubed (Europe) 1083 Ganshoren
Professeur J-J Body, Endocrinologie - Maladies Osseuses 1083 Ganshoren
SC3 1083 Ganshoren
MondayOpen 1083 Ganshoren
Looking for more information about EUROPHARMEDTECH?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is EUROPHARMEDTECH still active? Yes. The Crossroads Bank for Enterprises lists EUROPHARMEDTECH as active.

What is the VAT number of EUROPHARMEDTECH? The VAT number of EUROPHARMEDTECH is BE 0685.431.593.

When was EUROPHARMEDTECH founded? EUROPHARMEDTECH was founded on 28-11-2017.

What is the address of EUROPHARMEDTECH? The current registered office of EUROPHARMEDTECH is Avenue Charles-Quint 400, 1083 Ganshoren.

When did EUROPHARMEDTECH last file annual accounts? The latest annual accounts of EUROPHARMEDTECH were filed on 31-08-2026.

Does EUROPHARMEDTECH file its annual accounts on time? EUROPHARMEDTECH filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2025.

How many employees does EUROPHARMEDTECH have? EUROPHARMEDTECH employs 1.2 full-time equivalents according to its most recent annual accounts.

Is EUROPHARMEDTECH financially healthy? Addrly gives EUROPHARMEDTECH a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is EUROPHARMEDTECH profitable? The annual accounts of EUROPHARMEDTECH for 2025 show a loss of € 69 941.

What is the equity of EUROPHARMEDTECH? The equity of EUROPHARMEDTECH was € -28 814 at the close of the 2025 financial year.

Who are the directors of EUROPHARMEDTECH? The annual accounts of EUROPHARMEDTECH record 2 mandates. The names, roles and dates are visible with a free account.

Can EUROPHARMEDTECH receive Peppol e-invoices? Yes. EUROPHARMEDTECH is registered on the Peppol network and can receive structured electronic invoices.

What does EUROPHARMEDTECH do? The main activity of EUROPHARMEDTECH is: Scientific research and development.

Sources

How Addrly builds and refreshes this data